Treatment responses in antiretroviral treatment-naive premenopausal and postmenopausal HIV-1-infected women: An analysis from AIDS clinical trials group studies

Clinical Infectious Diseases

Volumn 49, Issue 3, 2009, Pages 473-476

  Patterson, Kristine B ^a   Cohn, Susan E ^b   Uyanik, Jennifer ^c   Hughes, Michael ^c   Smurzynski, Marlene ^c   Eron, Joseph J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LONG TERM CARE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; TREATMENT RESPONSE; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV-1; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; TREATMENT OUTCOME; UNITED STATES; VIRAL LOAD;

EID: 67651113460     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/600398     Document Type: Article

References (19)

1. UNAIDS W. AIDS Epidemic Update, December 2007. 2007.
2. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 2006. 2007.
3. Kojic EM, Wang CC, Cu-Uvin S. HIV and menopause: a review. J Womens Health (Larchmt) 2007;16:1402-11.
4. CASCADE Collaboration. Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well- estimated dates of seroconversion. J Acquir Immune Defic Syndr 2003;34: 76-83.
5. Prins M, Meyer L, Hessol NA. Sex and the course of HIV infection in the pre- and highly active antiretroviral therapy eras. AIDS 2005; 19:357-70.
6. Gandhi M, Bacchetti P, Miotti P, Veronese F, Greenblatt R. Does patient sex affect human immunodeficiency levels? Clin Infect Dis 2002;35: 313-22.
7. Napravnik S, Poole C, Thomas J, Eron J. Gender differences in HIV RNA levels: a meta-analysis of published studies. JAIDS 2002; 31:11-9.
8. Asin SN, Heimberg AM, Eszterhas SK, Rollenhagen C, Howell AL. Estradiol and progesterone regulate HIV type 1 replication in peripheral blood cells. AIDS Res Hum Retroviruses 2008; 24:701-16.
9. Gulick RM, Ribaudo HJ, Shikuma CM, et al. Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. N Engl J Med 2004; 350:1850-61.
10. Riddler SA, Haubrich R, DiRienzo AG, et al. Class-sparing regimens for initial treatment of HIV-1 infection. N Engl J Med 2008; 358:2095-106.
11. Paul SM, Martin RM, Lu SE, Lin Y. Changing trends in human immunodeficiency virus and acquired immunodeficiency syndrome in the population aged 50 and older. J Am Geriatr Soc 2007; 55:1393-7.
12. Sanders GD, Bayoumi AM, Holodniy M, Owens DK. Cost-effectiveness of HIV screening in patients older than 55 years of age. Ann Intern Med 2008; 148:889-903.
13. Lindau ST, Schumm LP, Laumann EO, Levinson W, O'Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med 2007; 357:762-74.
14. Patterson K, Napravnik S, Eron J, Keruly J, Moore R. Effects of age and sex on immunological and virological responses to initial highly active antiretroviral therapy. HIV Med 2007; 8:406-10.
15. Gulick RM, Ribaudo HJ, Shikuma CM, et al. Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial. JAMA 2006; 296:769-81.
16. Ribaudo HJ, Kuritzkes DR, Lalama CM, et al. Efavirenz-based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts. J Infect Dis 2008; 197:1006-10.
17. Muck W. Clinical pharmacokinetics of cerivastatin. Clin Pharmaco- kinet 2000; 39:99-116.
18. Orlando G, Meraviglia P, Cordier L, et al. Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients. HIV Med 2006; 7:549-57.
19. Manfredi R, Calza L, Cocchi D, et al. Antiretroviral treatment and advanced age: epidemiologic, laboratory, and clinical features in the elderly. J Acquir Immune Defic Syndr 2003; 33:112-4.